1. Introduction {#s0005}
===============

Oxidation-reduction chemistry forms an increasingly appreciated feature of biological signaling pathways, which includes the reversible oxidation of protein cysteine residues (Cys-SH) to influence protein structures and functions [@bib1], [@bib2]. In such redox signaling mechanisms, protein Cys-SH are oxidized by H~2~O~2~ generated by activation of e.g. NOX family NADPH oxidases or mitochondria, to initially generate intermediate sulfenic acids (Cys-SOH) and subsequent disulfide species [@bib3], [@bib4], [@bib5], [@bib6]. While a reactive and transient species, development of selective molecular probes, such as the 1,3-diketone-containing 5,5-dimethyl-1,3-cyclohexanedione (dimedone), have allowed for the detection of Cys-SOH in a range of proteins during biological redox signaling [@bib7], [@bib8], [@bib9]. Moreover, intermediate formation of Cys-SOH has been implicated in direct modulation of protein function, for example in the regulation of protein tyrosine kinases [@bib10], [@bib11], [@bib12].

Although formation of Cys-SOH is commonly appreciated as an intermediate in protein cysteine oxidation, some questions have been raised with respect to the specificity of dimedone-based reagents to detect them (e.g. [@bib6], [@bib13]). In this regard, it is becoming apparent that biological thiols can also exist in the form of hydropersulfide or polysulfide species (Cys-SS~n~H), in both low-molecular weight thiols (e.g. glutathione persulfide; GSSH) and in various proteins [@bib14], [@bib15], [@bib16], [@bib17]. The origin of such Cys-SS~n~H species is debated [@bib14], [@bib17], [@bib18], [@bib19], but likely sources involve some particular transsulfurases and the chemical reaction of cysteines or their oxidized derivatives with hydrogen sulfide (H~2~S), an important small molecule mediator in biological systems [@bib20], [@bib21], [@bib22], to generate hydropersulfide species (Cys-SSH) [@bib23], [@bib24], [@bib25]. Moreover, studies towards the chemical biology of Cys-SSH indicate that they have enhanced nucleophilic properties and one-electron reductant activity compared to corresponding sulfhydryl species, in part due to markedly reduced p*K*~a~ [@bib14], [@bib15], [@bib25]. Because of the common presence of protein cysteine persulfide species (R-SSH) in biological systems, we speculated that they represent important targets for cellular oxidants such as H~2~O~2~, leading to intermediate formation of perthiosulfenic acid species (R-SSOH), which are also detectable with dimedone-based reagents.

The present studies indeed indicate that a significant fraction of dimedone-metabolized proteins in resting or stimulated cells is susceptible to cleavage by thiol-based reductants such as DTT, suggesting the presence of Cys-SSOH species. Moreover, increases in apparent Cys-SSOH in various proteins in response to NADPH oxidase activation suggest that such previously unrecognized intermediate might play novel and unique roles in redox-based signaling.

2. Materials and methods {#s0010}
========================

2.1. Cell culture and treatments {#s0015}
--------------------------------

Human embryonic kidney cells (HEK293) or human pulmonary mucoepidermoid epithelial cells (NCI-H292) were grown in Dulbecco\'s Modified Eagle Medium (DMEM: Life Technologies) or RPMI 1640 medium containing 10% fetal bovine serum and 1% penicillin/streptomycin, respectively, as previously described [@bib26], [@bib27]. For experimentation, cells were seeded at 100,000 cells/well in 24-well plates or 500,000 in 6-well plates (Corning). For studies involving cell stimulation with ATP (Sigma, St. Louis, MO; 100 µM) or EGF (100 ng/mL Calbiochem), confluent cell monolayers were previously cultured overnight in the absence of serum. Following treatments, cell lysates were collected by placing cells on ice in 100 µL Western solubilization lysis buffer (50 mM HEPES, 250 mM NaCl, 1.5 mM MgCl~2~, 1% Triton-X100, 10% glycerol, 1 mmol/L ethyleneglycol-bis-(β-aminoethylether)-*N*,*N*,*N*^9^,*N*^9^-tetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 2 mM Na~3~VO~4~, 10 mg/mL aprotinin, and 10 mg/mL leupeptin; pH 7.4) per well for 30 min. Lysates were collected by scraping, briefly sonicated, and cleared of insoluble material by centrifugation (14,000 rpm, 5 min) for analysis.

### 2.2. Analysis of protein Cys-SOH or Cys-SSOH {#s0020}

For analysis of protein sulfenylation (Cys-SOH) and perthiosulfenylation (Cys-SSOH), cells were lysed in Western solubilization buffer (WSB) containing 1 mM DCP-bio1 (Kerafast or EMD Millipore Sigma), 200 U/mL catalase (Worthington, Lakewood, NJ) and 10 mM *N*-ethylmaleimide (Sigma) and incubated for 1 h on ice. Equal amounts of cell lysates were mixed with Laemli sample buffer, either in the presence or absence of 25 mmol/L DTT for 30 min, and separated by 10% SDS-PAGE for Western blotting with streptavidin-peroxidase (see below). For analysis of specific proteins of interest, excess DCP-bio1 reagent was removed from DCP-Bio1-derivatized lysates by 6 successive washes with 20 mM Tris-HCl (pH 7.4) on Amicon Ultra-0.5 Centrifugal Filter Devices (Millipore). DCP-bio1-tagged proteins were subsequently collected with high capacity NeutrAvidin-agarose beads (Pierce) and washed successively with 1% SDS, 4 mol/L urea, and 1 mol/L NaCl [@bib28]. Beads were then washed with 100 mmol/L ammonium bicarbonate either in the presence or absence of 10 mmol/L DTT for 30 min to assess the difference of sulfenic acid and perthiosulfenic acid tagged proteins.

### 2.3. Analysis of protein Cys-SSH {#s0025}

Analysis of protein hydropersulfides (Cys-SSH) was performed essentially as previously described [@bib16]. Briefly, H292 cells were serum starved, purged for 30 min with nitrogen, and lysed in WSB containing 1.0 mM Iodoacetyl-PEG2-biotin (IAB; Thermo) and 2000 U/mL catalase (bovine liver, Worthington) and incubated for 1 h on ice. Lysates containing \~ 200 µg protein were added to high capacity Neutravidin-agarose beads (Pierce) and washed 5 times with WSB followed by three washes of Tris-buffered saline (50 mM Tris-Cl, 150 mM NaCl, pH 7.4; TBS) including 0.05% SDS. The beads, which contain alkylated Cys-SH or Cys-SSH species, were then resuspended for 30 min in TBS containing 0.5% Tween-20 (TBST) in the presence of 25 mM DTT, to elute persulfide-containing proteins [@bib16]. Parallel samples were resuspended in the absence of DTT as a negative control. Both eluates were analyzed separately by Western blot, in comparison with residual proteins bound to these beads, which were eluted with reducing sample buffer (RSB) containing 125 mM Tris-Cl, 4% SDS, 20% w/v Glycerol, 0.5 mM β-mercaptoethanol, 0.02% bromophenol blue, pH 6.8). For appropriate comparison, equivalent volumes of each sample were analyzed.

2.4. Western blotting {#s0030}
---------------------

Cell lysates containing equal amounts of protein (15--35 µg, measured using BCA protein assay kit; Pierce) or proteins eluted from Neutravidin beads were mixed with reducing or non-reducing sample buffer (see above) and loaded on 10% SDS-PAGE gels and transferred to nitrocellulose membranes, and probed using antibodies against Src (L4A1; Cell Signaling 1∶1000), EGFR (C74B9 Cell Signaling 1:1000), or anti-cysteine sulfenic acid (Millipore Sigma; 07--2139; which specifically detects dimedone-conjugated cysteine residues) or with streptavidin peroxidase polymer ultrasensitive (1:10,000; Sigma). Primary antibodies were probed with rabbit or mouse-specific secondary antibodies conjugated with HRP (Cell Signaling) and detected by enhanced chemiluminescence (Pierce) using an Amersham 600 SE Imaging System. Western blot band densities were quantified using ImageQuant TL (v8.1.0.0).

2.5. DFT calculations {#s0035}
---------------------

Density functional theory (DFT) calculations were performed with Jaguar v8.4 [@bib29]. Gas-phase geometry optimizations were performed with the M06-L functional [@bib30] and 6--311++G\*\* basis set. Geometries obtained for ethanepersulfide (CH~3~-CH~2~-S-S-H) are consistent with geometric parameters from structurally defined hydropersulfides ([Table S1](#s0080){ref-type="sec"}, [Fig. S1](#s0080){ref-type="sec"}). [@bib31], [@bib32] Thermodynamic corrections to enthalpy and entropy were obtained from frequency calculations with the M06-L functional, and geometry minima were confirmed on the basis of no imaginary frequencies. Gas-phase electronic energies were corrected using the SM8 [@bib33], [@bib34] solvation model for solvation in water solvent. Solvation single point calculations were performed with M06 [@bib35], M06-2x [@bib35], B3LYP-3D [@bib36], PBE-D3 [@bib37], and PBE0-D3 [@bib38] to assess the variance in energies with a variety of functionals.

2.6. Identification of Cys-SOH and Cys-(S)~n~OH via dimedone labeling by liquid chromatography (LC)-electrospray ionization (ESI)-tandem mass spectrometry (MS/MS) (LC-ESI-MS/MS) {#s0040}
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Cys-SOH and Cys-(S)~n~OH were identified as dimedone adducts by LC-ESI-MS/MS. Specifically, Cys-SOH/Cys-(S)~n~OH were formed in the reaction of 0.1 mM [l]{.smallcaps}-cysteine and 0.3 mM Na~2~S~2~ in 10 mM Tris-HCl buffer (pH 7.4) as described below, yielding a reaction mixture containing 19% Cys-SH, 33% Cys-SSH, and 35% Cys-SSSH, as determined by labeling with β-(4-hydroxyphenyl)ethyl iodoacetamide (HPE-IAM). [@bib39] To the reaction mixture were added H~2~O~2~ (0--25 mM) and 5 mM dimedone, which were then were incubated at 37 °C for 3 h to form respective Cys-SOH/Cys-(S)~n~OH dimedone adducts. The reaction products treated with dimedone were diluted with 0.1% formic acid containing known amounts of isotope-labeled internal standards, which were then subjected to LC-ESI-MS/MS analyses as reported earlier [@bib15]. Multiple reaction monitoring (MRM) parameters for each dimedone adduct are summarized in [Table S4](#s0080){ref-type="sec"} in the [Supplementary Information](#s0080){ref-type="sec"}.

2.6.1. Preparation of Cys-S/Cys-(S)~n~-dimedone standards for LC-ESI-MS/MS analysis {#s0045}
-----------------------------------------------------------------------------------

Authentic Cys-S/CysS-(S)~n~-dimedone adducts were synthesized according to our method previously described with modifications, and were used as the standards for LC-ESI-MS/MS [@bib15]. To form Cys-(S)~n~H, 0.5 mM [l]{.smallcaps}-cysteine was reacted with 0.5 mM NaHS with NO generated from 0.5 mM 1-hydroxy-2-oxo-3-(*N*-methyl-3-aminopropyl)−3-methyl-1-triazene (Dojindo Laboratories, Kumamoto, Japan) in 10 mM Tris-HCl buffer (pH 7.4) under aerobic conditions at room temperature for 30 min, after which 2 mM H~2~O~2~ and 10 mM dimedone (Wako Pure Chemical Industries, Osaka, Japan) were added to the reaction mixture, and the mixtures were incubated further at 37 °C for 3 h to produce respective Cys-SOH/Cys-(S)~n~OH adducts. Similarly, stable isotope-labeled dimedone adducts of CysS-(^34^S)~n~OH were synthesized by reacting dimedone with CysS-(^34^S)~n~OH formed with cysteine and polysulfides generated with NaH^34^S instead of NaH^32^S. Various dimedone adducts thus synthesized were purified by HPLC (Prominence; Shimadzu Corporation, Kyoto, Japan), on a reverse-phase column (YMC-Triart C18 column, 50 × 2.0 mm inner diameter; YMC, Kyoto, Japan) under the following elution conditions: mobile phases A (0.1% formic acid) and B (0.1% formic acid in methanol) with a linear gradient from 5% to 90% B for 15 min at a flow rate of 0.2 mL/min at 40 °C.

3. Results and discussion {#s0050}
=========================

3.1. Dimedone labeling of cellular proteins reveals the presence of DTT-reducible adducts {#s0055}
-----------------------------------------------------------------------------------------

Detection of protein sulfenic acids (Cys-SOH) is typically performed using dimedone-based probes and analysis under reducing conditions (ie. in the presence of DTT). However, when HEK293 cells were incubated in the presence of dimedone for 2 h, and subsequently lysed and mixed with Laemlli sample buffer in either the absence or presence of DTT, subsequent SDS-PAGE and Western blot analysis with an α-dimedone antibody indicated that formation of dimedone-adducts was significantly more prominent when analyzed under non-reducing conditions ([Fig. 1](#f0005){ref-type="fig"}A), suggesting that a substantial fraction of detected adducts represents Cys-SS~n~-dimedone (n ≥ 1) conjugates. Similar findings were observed in NCI-H292 human pulmonary mucoepidermoid cells and analysis of cell lysates with the sulfenic acid probe DCP-bio1, which were subsequently mixed with SDS-PAGE sample buffer in the presence or absence of DTT, and analyzed by blotting with streptavidin-HRP to detect DCP-Bio1-tagged proteins ([Fig. 1](#f0005){ref-type="fig"}B) [@bib7], [@bib28]. In this case, we also addressed potential formation of Cys-SOH in response to cellular H~2~O~2~ production by cell stimulation with either exogenous ATP (100 µM) or epidermal growth factor (EGF; 100 ng/mL), which activate the NOX enzymes DUOX1 and NOX2, respectively [@bib12], [@bib27]. Indeed, cell stimulation with ATP and EGF promoted increased DCP-bio1-tagged proteins analyzed under reducing conditions, as expected, but more dramatically enhanced overall intensity of DCP-bio1-tagged protein bands when analyzed under non-reducing conditions (in the absence of DTT) ([Fig. 1](#f0005){ref-type="fig"}B). Although our findings indicate the presence of Cys-SS~n~-DCP-bio1 species, that would have gone undetected under reducing conditions, it is alternatively possible that reductants such as DTT may also be capable of reversing Cys-S-dimedone adducts, thus minimizing their detection [@bib40], [@bib41]. To address this, we performed LC-MS/MS analysis of preformed dimedone adducts of Cys-SH or Cys-SSH and followed their decomposition in the presence of various concentrations of DTT. As illustrated in [Fig. 2](#f0010){ref-type="fig"}, while DTT induced dose-dependent degradation of Cys-SS-dimedone, due to cleavage of its disulfide bond, it did not significantly degrade Cys-S-dimedone adducts, even at concentrations of 100 mM. Hence, our observation of DTT-reducible dimedone-tagged proteins reflects the presence of Cys-SS~n~-dimedone species, which most likely originated from dimedone labeling of oxidized persulfide species (Cys-SS~n~OH) species, by forming additional Cys-SS~n~-dimedone adducts, was also tested in several cell-based studies. Indeed, formation of such oxidized persulfides has been implicated previously during oxidation of mercaptopyruvate sulfurtransferase [@bib42], but our findings indicate that such formation of thiosulfenate (Cys-S-SO^-^) or perthiosulfenic acid species occurs more widely in a large number of cellular proteins.Fig. 1Analysis of dimedone labeling of protein sulfenic acids under reducing or non-reducing conditions. (A) HEK293 cells were incubated in the presence of indicated concentrations of dimedone, and cells were lysed and mixed with Laemlli sample buffer in the presence or absence of DTT before analysis by Western blot using α-dimedone antibody. (B) Analysis of DCP-Bio1-tagged proteins in H292 cells upon 10-min stimulation with either ATP (100 µM) or EGF (100 ng/mL) under reducing (+ DTT) or non-reducing (- DTT) conditions. Representative blots of 3 separate experiments are shown.Fig. 1Fig. 2Analysis of decomposition of Cys-S-dimedone or Cys-SS-dimedone in the presence of DTT. Preformed Cys-S-dimedone and Cys-SS-dimedone adducts (10 nM each) were incubated in the presence of various concentrations of DTT in 30 mM HEPES buffer (pH 7.5) at 37 °C for 1 h, followed by quantification by LC-ESI-MS/MS analysis. Data are means ± s.d. (n = 4). \**P* \< 0.05; \*\**P* \< 0.01 (vs. 0 mM DTT).Fig. 2

3.2. DFT calculations and LC-MS/MS analysis predict facile oxidation of RSSH to RSSOH and labeling with dimedone {#s0060}
----------------------------------------------------------------------------------------------------------------

To support our proposed detection of Cys-SS~n~-dimedone species due to derivatization of Cys-SS~n~OH, we performed density functional theory (DFT) calculations on ethanethiol (Et-SH) and ethyldisulfane (Et-SSH) models, to predict the relative reactivity of H~2~O~2~ with R-SSH compared to R-SH with respect to generating corresponding sulfenic acids (R-SSOH versus R-SOH), as well as their subsequent reaction with dimedone. We first calibrated DFT geometries with X-ray crystal structures of hydropersulfide species [@bib31], [@bib32] ([Fig. S1](#s0080){ref-type="sec"}, [Table S2](#s0080){ref-type="sec"}) and determined that computed ΔG°'s are consistent with a set of diverse methods ([Tables S3 and S4](#s0080){ref-type="sec"}, [Figs. S2 and S3](#s0080){ref-type="sec"}). In line with our hypothesis, ΔG°'s for H~2~O~2~-dependent oxidation of Et-SSH to Et-SSOH were calculated to be \~ 6.2 kcal/mol more favorable compared to similar oxidation of Et-SH to Et-SOH ([Fig. 3](#f0015){ref-type="fig"}). Moreover, conjugation of either Et-SOH and Et-SSOH with the dimedone-like compound cyclohexane-1,3-dione is in both cases exergonic, although Et-SOH reacts with dimedone \~ 5.7 kcal/mol more favorably compared to Et-SSOH ([Fig. 3](#f0015){ref-type="fig"}). Hence, these calculations predict that R-SSH species are readily oxidized by H~2~O~2~ to R-SSOH, relative to comparable oxidation of R-SH to R-SOH, and that both R-SOH and R-SSOH are reactive towards dimedone to form stable adducts. Dimedone probes are not reactive towards R-SH, but could conceivably react with Cys-SSH to form Cys-S-dimedone with elimination of H~2~S. However, computed values of ΔG° indicate that dimedone adduction to Et-SSH is energetically uphill by \~ 7.6 kcal/mol (\~ 15.1 kcal/mol less favorable compared to dimedone reacting with Et-SSOH), suggesting that dimedone is highly selective towards R-SOH or R-SSOH species compared to R-SSH species ([Fig. S4](#s0080){ref-type="sec"}). Overall, these calculations predict that R-SSH can be readily oxidized to R-SSOH and that commonly employed dimedone compounds used to trap R-SOH are also capable of trapping R-SSOH. In an attempt to experimentally confirm the ability of dimedone to detect R-SSOH, we prepared Cys-S~n~H species by reacting [l]{.smallcaps}-cysteine with Na~2~S~2~ and analyzed reaction products with H~2~O~2~ and dimedone with LC-MS/MS ([Fig. 4](#f0020){ref-type="fig"}; [Table S4](#s0080){ref-type="sec"}) [@bib15]. As shown, H~2~O~2~ induced dose-dependent formation of Cys-S-dimedone and especially Cys-SS-dimedone and Cys-SSS-dimedone, reflecting intermediate formation of Cys-S~n~OH. The greater yield of Cys-SS-dimedone and Cys-SSS-dimedone species compared to Cys-S-dimedone is consistent with the greater susceptibility of perthiol species (Cys-SSH, Cys-SSSH) to oxidation by H~2~O~2~. Autoxidation of Cys-SS~n~H likely accounts for detection of dimedone adducts in the absence of H~2~O~2~, since direct reaction of dimedone with Cys-SS~n~H is deemed unlikely based on DFT calculations ([Fig. S4](#s0080){ref-type="sec"}). Finally, the observed decrease in dimedone adducts at \[H~2~O~2~\] \> 5.0 mM most likely reflects further oxidation of Cys-SS~n~H to sulfinic and sulfonic acid species, which are unreactive with dimedone. In aggregate, these analyses support the formation of Cys-SSOH during oxidation of protein persulfides and its detection using dimedone-based probes.Fig. 3DFT models and computed Gibbs Free Energies of the oxidation of (A) Et-SH to Et-SOH and (B) Et-SSH to Et-SSOH by H~2~O~2~ and subsequent reaction with dimedone to form (A) Et-S-dimedone and (B) Et-SS-dimedone.Fig. 3Fig. 4Analysis of dimedone derivatization of Cys-(S)~n~OH by LC-MS/MS. Quantitative identification of Cys-(S)~n~OH formed during reaction of Cys-(S~n~)H with H~2~O~2~ by derivatization with dimedone, as described in Materials and Methods. Data are representative of 2--3 separate analyses.Fig. 4

### 3.3. Protein tyrosine kinases contain persulfide species that are susceptible to H~2~O~2~ {#s0065}

Previous studies have indicated that NOX-dependent H~2~O~2~ production, in response to stimulation with extracellular ATP or EGF regulates the activation of redox-sensitive tyrosine kinases such as epidermal growth factor receptor (EGFR) and Src, by sulfenylation of conserved cysteines within their kinase domains [@bib12], [@bib27], [@bib43], [@bib44]. Indeed, epithelial cell stimulation with ATP and EGF was found to generate H~2~O~2~ by activation of DUOX1 and NOX2, respectively [@bib12], [@bib45]. Since both ATP and EGF enhance formation of DTT-reducible dimedone conjugates ([Fig. 1](#f0005){ref-type="fig"} B), we speculated whether Cys-SSOH may be formed in these kinases due to oxidation of pre-existing Cys-SSH species. To this end, DCP-Bio1-derivatized cell lysates from ATP- or EGF-stimulated H292 cells ([Fig. 1](#f0005){ref-type="fig"}) were subjected to neutravidin purification [@bib7], [@bib28], and neutravidin-purified proteins were washed in the presence or absence of DTT prior to elution in reducing sample buffer (RSB), and then analyzed by SDS-PAGE and Western blotting for EGFR or Src. As shown, greater amounts of DCP-Bio1-labeled EGFR and Src were recovered from ATP- or EGF-stimulated cells under non-reducing washing conditions when compared to washing conditions that included DTT ([Fig. 5](#f0025){ref-type="fig"}), indicating the formation of reducible DCP-Bio1 conjugates in these proteins in response to ATP and EGF that likely reflect the presence of Cys-SS~n~OH within these proteins. Quantification of relative band densities indicates that DCP-Bio1 tagging of EGFR and Src in cells treated with either stimulus was \~ 60--120% higher in the absence of DTT washing ([Fig. 5](#f0025){ref-type="fig"}B), suggesting that a significant portion of DCP-Bio1 reactivity within these proteins may actually reflect the presence of Cys-SS~n~OH intermediates, as potentially relevant post-translational modifications in redox signaling. One potential caveat in these measurements is that DTT reduction may also lead to recovery of proteins that are indirectly bound through intermolecular disulfides to DCP-bio1-conjugated proteins, which would be mistakenly attributed to Cys-SSOH-containing proteins. However, to our knowledge there is no evidence for intermolecular disulfide crosslinking of EGFR with other proteins, although this may be true for Src [@bib46]. Therefore, we assume that our findings reflect the presence of Cys-SS~n~OH within EGFR and Src. Another issue worth considering is that alkylating agents, such as *N*-ethylmaleimide (NEM; which was used in lysis buffers in these studies), can react with Cys-SOH species [@bib41] and potentially also with Cys-SSOH, although it would have to outcompete reactions of dimedone or DCP-Bio1 with these products. If anything, this would not invalidate our conclusions and would in fact result in underestimation of the amounts of Cys-SOH and Cys-SSOH species.Fig. 5**(**A) Representative Western blot analysis of Cys-SSOH species in EGFR and Src in stimulated H292 cells by DCP-bio1 labeling and avidin capture and processing in the presence or absence of DTT. (B) Densitometry analysis of relative band density of Western blots from 8 replicates from 3 independent experiments. Ratios were arbitrarily set at 1 for EGF-stimulated samples analyzed with DTT. Data represents means ± s.e.m. \* *P* \< 0.05 and \*\* *P* \< 0.01 based on Student\'s *t*-test.Fig. 5

If our findings indeed reflect the formation of Cys-SS~n~OH species within EGFR and Src in response to H~2~O~2~ production, this would imply that a fraction of Cys residues within these kinases exists as Cys-SS~n~H. To address this, we utilized a recently developed procedure to detect the presence of protein Cys-SS~n~H, ProPerDP [@bib16], based on alkylation of both Cys-SH and Cys-SSH with Iodoacetyl-PEG2-Biotin (IAB) and differential elution of avidin-purified proteins in the presence or absence of DTT. As shown in [Fig. 6](#f0030){ref-type="fig"}, analysis of DTT-eluted proteins from avidin-purified IAB-derivatized proteins from H292 cell lysates indeed revealed detectable amounts of EGFR and Src, indicating the presence of Cys-SS~n~H, in comparison to control elution in the absence of DTT ([Fig. 6](#f0030){ref-type="fig"}; left 6 lanes). Analysis of avidin-purified proteins using SDS-containing reducing sample buffer (RSB), which represents combined IAB-tagged Cys-SH and Cys-SS~n~H species, indicated slightly lower recovery of EGFR and Src from avidin beads that were initially prewashed with DTT ([Fig. 6](#f0030){ref-type="fig"}; right 6 lanes), thus indirectly demonstrating the presence of Cys-SS~n~H in both proteins. It is important to consider some technical limitations of this methodology [@bib16]. First, EGFR and Src contain multiple cysteine residues, and potential IAB conjugation of both Cys-SH and Cys-SSH within the same protein would render Cys-SSH undetectable with this method. Additionally, as is also the case for the DCP-bio1 experiments in [Fig. 5](#f0025){ref-type="fig"}, DTT reduction could lead to an increase in the signal for EGFR and Src bound through intermolecular disulfides and would be mistakenly identified as Cys-SSH-containing proteins. However, and as mentioned previously, this is expected to be negligable. Since IAB can react with Cys-SOH and thus presumably also with Cys-SSOH, our analysis of Cys-SSH might also include Cys-SSOH. Lastly, our analysis of Cys-SSH may also be compromised by reaction of IAB with Cys-SOH to the corresponding Cys-SOR adduct, which could be reduced by DTT during the initial elution step. This would mean that this detection method for Cys-SSH might inadvertently also detect some Cys-SOH. However, since the reduction of Cys-SOR by DTT is rather slow (\< 50% after 1 h [@bib42]), we believe this is a relatively minor concern. Notwithstanding these limitations, the present findings strongly indicate the presence of Cys-SS~n~H within these protein kinases and quantification of relative Western blot band densities suggests that \~ 5--8% of all reduced Cys residues within EGFR and Src may exist as Cys-SS~n~H ([Fig. 6](#f0030){ref-type="fig"}B). The estimated proportion of Cys-SS~n~-dimedone in overall dimedone conjugates in these proteins in response to cellular H~2~O~2~ production ([Fig. 5](#f0025){ref-type="fig"}B) would suggest that Cys-SS~n~H indeed appears to be a preferred target compared to Cys-SH for oxidation to corresponding Cys-SS~n~OH intermediates, in agreement with our DFT calculations and LC-MS/MS analysis.Fig. 6(A) Representative Western blot analysis of Cys-SSH within EGFR and Src in H292 cells, by lysis in the presence of IAB, following by avidin capture and initial elution in the presence or absence of DTT (-RSB) and subsequent elution with SDS-containing reducing sample buffer (RSB). (B) Relative band densities of Western blot analysis of avidin-captured proteins, normalized to input lysates (with ratios of --DTT; + RSB sample arbitrarily set at 1). Data represents means ± s.e.m from 3 replicates.Fig. 6

4. Conclusions {#s0070}
==============

In summary, the present work indicates that dimedone trapping approaches that are commonly used to detect protein sulfenylation (Cys-SOH) can also detect Cys-SS~n~OH species, and implicates Cys-SSOH as a previously unrecognized species as a potential additional intermediate in thiol-based redox signaling. Importantly, while previous efforts to identify sulfenylated proteins, in so-called "sulfenomes", commonly use biotin-tagging approaches and avidin capture under reducing conditions [@bib7], [@bib47], [@bib48], alternative approaches have been reported that do not and would potentially also include Cys-SSOH in their sulfenome analysis [@bib49]. Additionally, evidence is emerging for the biological significance of Cys-SOH in redox-dependent activation of e.g. protein kinases such as EGFR and Src [@bib11], [@bib50], [@bib51], the functional importance of Cys-SS~n~H or Cys-SS~n~OH within these proteins is still unclear. Given the general importance of non-catalytic cysteine residues within protein kinases in redox regulation or as a target for irreversible kinase inhibitors [@bib52], [@bib53], our findings warrant future studies to assess the biological relevance of Cys-SS~n~H and Cys-SS~n~OH intermediates within these proteins. Identification of these and related novel intermediates further exemplifies the expanding pleiotropic nature of redox-dependent protein regulation by reversible cysteine modifications.
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==================================
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